Survey of Ophthalmology
Volume 45, Supplement 3 , Pages S284-S289, May 2001

Efficacy and Safety of Memantine, an NMDA-Type Open-Channel Blocker, for Reduction of Retinal Injury Associated with Experimental Glaucoma in Rat and Monkey☆

Department of Biological Sciences, Allergan, Inc., Irvine, CA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The authors are employed by Allergan, Inc., Irvine, CA, USA.

PII: S0039-6257(01)00200-4

Survey of Ophthalmology
Volume 45, Supplement 3 , Pages S284-S289, May 2001

Article Tools

* Image Usage & Resolution